Biomarker Panel

Biomarkers, particularly molecular biomarkers, are key indicators of biological processes in normal and diseased conditions. Recent research on their role in pathogenesis, coupled with the advancement of laboratory technology, has allowed for the objective measurement of biomarkers at a cellular level. This increase in research on molecular biomarkers has yielded more information for clinical investigators to properly assess disease diagnosis, prognosis, treatment, and management. Since 2003, the FDA has approved 139 tests for biomarkers.

Refer to our Biomarker Panel for a collection of articles that used our SSNA probes to address key challenges in cancer research and presented with initial validation studies